The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

SiliconANGLEValley

AI drug development startup Pathos AI closes $237M investment

10.23

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation. Pharmaceutical giant Bristol Myers Squibb Co.

Funding & deals

Read at SiliconANGLE ↗

One letter a week, starting soon.

Latest

AI drug development startup Pathos AI closes $237M investment

Related

ValleyIn AI, it’s a tale of two diverging investor classes SiliconANGLE

ValleyReport: OpenAI closing on $30B ‘bridge’ funding round to tide it over before IPO SiliconANGLE

ValleyMave raises $34M to pull existing security tools into one agentic system SiliconANGLE

ValleyEx-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry SiliconANGLE

ValleyRobotics startup Enact Intelligence nabs $30M funding round SiliconANGLE

ValleyNirva raises $25M to make AI jewelry with ‘perspective’ that listens and provides insights SiliconANGLE